RESUMEN
Transfusion transmitted human cytomegalovirus [TT-HCMV] infections has been documented in a wide variety of clinical circumstances and can be the cause of significant morbidity and mortality in immunocompromised patients. This study was designed to investigate the prevalence of cytomegalovirus IgG antibody in 80 blood donors [44 professionals and 36 volunteers]. The seroprevalence was 52.5% in all blood donors. The seroprevalence was insignificant as regards the type of blood donormage, residence history of blood transfusion, and history of surgical operation. Prevention of TT-HCMV infection through the manipulation of blood products either by serologic screening or leukocytes reduction is the preferred approach in the HCMV seronegative recipients